|Home||» Products||» Active Pharmaceutical Ingredients||» Letrozole|
Product Name : Letrozole
Grade : IP / BP / USP
Therapeutic Category : Antineoplastic
CAS No : 112809-51-5
Appearance: white to off-white powder
Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.
Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.
North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .
Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.
OCEANIA: Australia, New Zealand, Fiji, etc.
Letrozole Manufacturers India,Letrozole suppliers India,Letrozole Exporters India,Letrozole Powder Manufacturer India,Letrozole Powder Supplier India,Letrozole API Manufacturer India,Letrozole API Suppliers India,Buy Letrozole Online India,Letrozole Price,Letrozole Bulk Drugs Manufacturer India,Letrozole